Hogy Medical Co.,Ltd. (HGYMF)
USD 24.34
(0.0%)
USD 24.34
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 3.66 Billion JPY | -35.27% |
| 2023 | 42.66 Million JPY | -32.26% |
| 2022 | 62.98 Million JPY | 0.0% |
| 2021 | - JPY | -100.0% |
| 2020 | 1.62 Million JPY | -37.04% |
| 2019 | 2.57 Million JPY | -31.37% |
| 2018 | 3.75 Million JPY | -17.7% |
| 2017 | 4.55 Million JPY | 0.0% |
| 2016 | - JPY | 0.0% |
| 2015 | - JPY | 0.0% |
| 2014 | - JPY | 0.0% |
| 2013 | - JPY | 0.0% |
| 2012 | - JPY | 0.0% |
| 2011 | - JPY | -100.0% |
| 2010 | 925 Million JPY | -51.95% |
| 2009 | 1.92 Billion JPY | -34.19% |
| 2008 | 2.92 Billion JPY | -25.48% |
| 2007 | 3.92 Billion JPY | 0.0% |
| 2006 | - JPY | 0.0% |
| 2005 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | 3.66 Billion JPY | 8499.95% |
| 2024 Q1 | 35.8 Million JPY | -8.82% |
| 2024 Q2 | 31.23 Million JPY | -9.67% |
| 2024 Q4 | 3.66 Billion JPY | -11.99% |
| 2024 Q3 | 29.54 Million JPY | -10.69% |
| 2023 Q3 | 47.02 Million JPY | 2.1% |
| 2023 FY | 42.66 Million JPY | -32.26% |
| 2023 Q4 | 42.66 Million JPY | -9.28% |
| 2023 Q1 | 52.77 Million JPY | -16.2% |
| 2023 Q2 | 46.05 Million JPY | -12.74% |
| 2022 Q4 | 62.98 Million JPY | 0.0% |
| 2022 FY | 62.98 Million JPY | 0.0% |
| 2022 Q3 | - JPY | 0.0% |
| 2022 Q1 | - JPY | 0.0% |
| 2022 Q2 | - JPY | 0.0% |
| 2021 Q2 | - JPY | -100.0% |
| 2021 Q4 | - JPY | 0.0% |
| 2021 Q3 | - JPY | 0.0% |
| 2021 FY | - JPY | -100.0% |
| 2021 Q1 | 175 Million JPY | 0.0% |
| 2020 Q4 | 175 Million JPY | -23.91% |
| 2020 Q1 | 285 Million JPY | 0.0% |
| 2020 FY | 1.62 Million JPY | -37.04% |
| 2020 Q2 | 230 Million JPY | -19.3% |
| 2020 Q3 | 230 Million JPY | 0.0% |
| 2019 Q4 | 285 Million JPY | -16.42% |
| 2019 Q2 | 341 Million JPY | -14.54% |
| 2019 Q1 | 399 Million JPY | 0.0% |
| 2019 Q3 | 341 Million JPY | 0.0% |
| 2019 FY | 2.57 Million JPY | -31.37% |
| 2018 Q3 | 453 Million JPY | 0.0% |
| 2018 Q1 | 508 Million JPY | 0.0% |
| 2018 FY | 3.75 Million JPY | -17.7% |
| 2018 Q4 | 399 Million JPY | -11.92% |
| 2018 Q2 | 453 Million JPY | -10.83% |
| 2017 Q3 | 566 Million JPY | 0.0% |
| 2017 Q2 | 566 Million JPY | 0.0% |
| 2017 Q1 | - JPY | 0.0% |
| 2017 FY | 4.55 Million JPY | 0.0% |
| 2017 Q4 | 508 Million JPY | -10.25% |
| 2016 Q3 | - JPY | 0.0% |
| 2016 FY | - JPY | 0.0% |
| 2016 Q4 | - JPY | 0.0% |
| 2016 Q2 | - JPY | 0.0% |
| 2016 Q1 | - JPY | 0.0% |
| 2015 FY | - JPY | 0.0% |
| 2015 Q4 | - JPY | 0.0% |
| 2015 Q1 | - JPY | 0.0% |
| 2015 Q2 | - JPY | 0.0% |
| 2015 Q3 | - JPY | 0.0% |
| 2014 Q4 | - JPY | 0.0% |
| 2014 Q3 | - JPY | 0.0% |
| 2014 Q2 | - JPY | 0.0% |
| 2014 Q1 | - JPY | 0.0% |
| 2014 FY | - JPY | 0.0% |
| 2013 FY | - JPY | 0.0% |
| 2013 Q3 | - JPY | 0.0% |
| 2013 Q1 | - JPY | 0.0% |
| 2013 Q2 | - JPY | 0.0% |
| 2013 Q4 | - JPY | 0.0% |
| 2012 Q4 | - JPY | 0.0% |
| 2012 FY | - JPY | 0.0% |
| 2012 Q3 | - JPY | 0.0% |
| 2012 Q1 | - JPY | 0.0% |
| 2012 Q2 | - JPY | 0.0% |
| 2011 Q3 | - JPY | -100.0% |
| 2011 Q4 | - JPY | 0.0% |
| 2011 FY | - JPY | -100.0% |
| 2011 Q1 | 500 Million JPY | -45.95% |
| 2011 Q2 | 425 Million JPY | -15.0% |
| 2010 Q2 | 1.42 Billion JPY | 0.0% |
| 2010 Q3 | 1 Billion JPY | -29.82% |
| 2010 FY | 925 Million JPY | -51.95% |
| 2010 Q4 | 925 Million JPY | -7.5% |
| 2009 Q4 | 1.92 Billion JPY | -3.75% |
| 2009 FY | 1.92 Billion JPY | -34.19% |
| 2009 Q3 | 2 Billion JPY | 0.0% |
| 2008 FY | 2.92 Billion JPY | -25.48% |
| 2007 FY | 3.92 Billion JPY | 0.0% |
| 2006 FY | - JPY | 0.0% |
| 2005 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -420.221% |
| Ansell Limited | 706.6 Million USD | -419.247% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -16271.013% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -586940.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -199.469% |
| ConvaTec Group Plc | 1.22 Billion USD | -199.046% |
| Encision Inc. | 67.33 Thousand USD | -5448694.107% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -958271.317% |
| LifePoint, Inc. | 151.73 Thousand USD | -2417947.372% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -74564.225% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -596485.366% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -2038652.41% |
| SmileDirectClub, Inc. | 849.37 Million USD | -331.963% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -1640.678% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -7566564.604% |
| Vasamed, Inc. | 18.95 Thousand USD | -19361377.573% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -19866696.621% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -939597.012% |